Management and impact of obesity in Canada: A real-world survey of people with obesity and their physicians
Among PwO participating in our study, ORCs were common, often uncontrolled, and their presence impacted the likelihood of obesity treatment and possibly impaired work productivity. Medical treatment for obesity was often delayed until ORCs developed, suggesting that preventative healthcare measures are not the norm for PwO in Canada. A large proportion of PwO had high socioeconomic status, suggesting that PwO who access treatment may not be representative of the overall population of PwO in Canada.
Authors
- Esther Artime (ORCID: https://orcid.org/0000-0003-4294-6462)
- Andrea Leith (ORCID: https://orcid.org/0000-0002-1147-5306)
- Jennifer M. Glass
- Jennifer L. Kuk (ORCID: https://orcid.org/0000-0002-3425-6149)
- David C.W. Lau (ORCID: https://orcid.org/0000-0002-1780-9039)
- Victoria Higgins (ORCID: https://orcid.org/0000-0002-3901-7390)
- Lewis Harrison (ORCID: https://orcid.org/0009-0006-1164-8373)
- Ian Patton (ORCID: https://orcid.org/0009-0004-6588-5003)
- Sophie Carter
Institutions
- University of Calgary (CA)
- York University (CA)
- Canadian Obesity Network (CA)
- Adelphi Group (United Kingdom) (GB)
- Eli Lilly (Spain) (ES)
- Eli Lilly (Canada) (CA)
Publication Details
- Journal
- Obesity Pillars
- Published
- 2025-02-28
- DOI
- https://doi.org/10.1016/j.obpill.2025.100171
- Primary Topic
- Obesity and Health Practices
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Eli Lilly and Company